title: Clots kill: hematologic pharmacology for ST-segment elevation myocardial infarction.
abstract: Drugs that work on the hematologic system play an important role in helping to limit the morbidity and mortality that can be associated with an acute coronary syndrome. The pharmacology of the fibrinolytic agents, thrombin inhibitors, and antiplatelet agents is described. A case study of a woman having an ST-segment elevation myocardial infarction is reviewed to highlight the importance of drugs that work on the hematologic system.
authors.affiliation: Queen of the Valley Medical Center in Napa, California 94558, USA. stacyhealy@sbcglobal.net
authors.forename: Stacy H
authors.initials: SH
authors.lastname: James
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D003422:Critical Care; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007362:Intensive Care Units; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000628:therapy; D061214:Patient Safety; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011859:Radiography; D018570:Risk Assessment; D012720:Severity of Illness Index; D015912:Thrombolytic Therapy / Q000379:methods; D013927:Thrombosis / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors